BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $101,462 | -94.4% | 2,227 | -95.0% | 0.01% | -94.5% |
| Q1 2023 | $1,801,229 | -63.1% | 44,409 | -53.7% | 0.13% | -63.7% |
| Q4 2022 | $4,885,424 | +268.2% | 95,849 | +288.7% | 0.35% | +250.0% |
| Q3 2022 | $1,327,000 | -15.3% | 24,656 | +1.1% | 0.10% | -30.6% |
| Q2 2022 | $1,566,000 | -81.4% | 24,384 | -77.5% | 0.14% | -80.4% |
| Q1 2022 | $8,409,000 | +291.3% | 108,459 | +306.2% | 0.73% | +333.7% |
| Q2 2021 | $2,149,000 | -6.2% | 26,700 | -6.3% | 0.17% | -35.7% |
| Q3 2020 | $2,292,000 | -34.4% | 28,504 | -29.8% | 0.26% | -43.1% |
| Q2 2020 | $3,495,000 | +20.5% | 40,602 | +17.0% | 0.46% | +60.4% |
| Q4 2019 | $2,901,000 | -10.3% | 34,699 | -6.2% | 0.29% | -9.7% |
| Q3 2019 | $3,235,000 | -58.5% | 36,987 | -63.4% | 0.32% | -41.5% |
| Q3 2018 | $7,790,000 | +73.6% | 101,057 | +66.2% | 0.54% | +78.1% |
| Q2 2018 | $4,488,000 | -53.2% | 60,792 | -58.8% | 0.31% | -63.0% |
| Q1 2018 | $9,592,000 | +137.0% | 147,486 | +135.6% | 0.83% | +120.3% |
| Q4 2017 | $4,047,000 | +129.4% | 62,613 | +122.7% | 0.38% | +121.9% |
| Q3 2017 | $1,764,000 | -16.0% | 28,119 | -40.6% | 0.17% | -27.5% |
| Q4 2016 | $2,099,000 | +103.4% | 47,341 | +118.3% | 0.23% | +102.6% |
| Q3 2016 | $1,032,000 | -53.1% | 21,691 | -55.4% | 0.12% | -50.9% |
| Q2 2016 | $2,199,000 | +9.8% | 48,636 | -0.2% | 0.23% | -27.1% |
| Q1 2016 | $2,002,000 | -44.3% | 48,745 | -48.3% | 0.32% | -47.9% |
| Q4 2015 | $3,593,000 | +521.6% | 94,203 | +434.5% | 0.62% | +509.9% |
| Q3 2015 | $578,000 | +189.0% | 17,625 | +543.7% | 0.10% | +57.8% |
| Q4 2014 | $200,000 | -67.2% | 2,738 | -67.8% | 0.06% | -23.8% |
| Q3 2014 | $609,000 | -45.6% | 8,498 | -44.2% | 0.08% | -68.2% |
| Q1 2014 | $1,120,000 | – | 15,233 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |